A new research report by Transparency Market Research features current trends in kidney function tests and briefs readers about key developments adopted by key companies operating in the market. The report also highlights key factors restricting and boosting the growth of the global kidney function tests market. As per the findings, the rising healthcare expenditure and the rising stringent regulatory approvals are expected to hamper the global market. Some of the factors predicted to propel the global kidney function market are the rising aging population, the rising number of people facing diabetes, and the increasing prevalence of renal fibrosis. Renal tests comprise several categories such as dilution and concentration tests and physical and visual examination of urine.
The report, titled “Kidney Function Tests Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,” states that the market will benefit from the rising number of people facing chronic kidney diseases. According to the World Health Organization, every year, approximately 1.4 million people undergo renal replacement therapy. Other problems arising from high blood pressure are further contributing towards the growing incidence of chronic kidney diseases, which is likely to boost the demand for kidney function tests.
By region, the global kidney function tests market is divided into North America, Asia Pacific, Europe, the Middle East, Latin America, and Rest of the World. Currently, the market is dominated by North America, followed by Europe. The rising occurrence of kidney-related diseases in the United States, the rising awareness of kidney function tests, developed healthcare infrastructure, and high affordability are some of the factors responsible for the growth of the North America kidney function tests market. Going forward, Asia Pacific is expected to be the fastest growing market for kidney function test, owing to the rising awareness about healthcare, the rising demand for therapeutics and diagnostics rules for kidney diseases, and the increasing pool of diabetic people.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5810
The report lists key companies operating in the global kidney function tests market. As per the findings of the report, the global market is highly competitive in nature. The presence of leading companies and the entry of new players is likely to make the market more mature in the near future. Some of the key companies listed in the report are F. Hoffmann-La Roche Ltd., Galectin Therapeutics, Inc., Discovery Biomed, Inc., Kadmon Corporation, LLC, Eli Lilly and Company, IC-Meditech, Inc., ManRos Therapeutics, Metabolic Solutions Development Company, LLC, Baxter International Inc., Otsuka Holdings Co., Ltd., Ipsen S.A., Plexxikon Inc., and Endocyte, Inc.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453